Safety, Efficacy, and Biomarker Analysis of Deulorlatinib (TGRX-326) in Anaplastic Lymphoma Kinase-Positive NSCLC: A Multicenter, Open-Label, Phase 1/1b Trial
| Autor: | Zhao, Shen, Zhou, Huaqiang, Yang, Nong, Wang, Zhehai, Jin, Wenjian, Ma, Yuxiang, Xue, Jinhui, Li, Xingya, Liu, Yunpeng, Meng, Rui, Zhou, Jianying, Cheng, Ying, Wang, Yongsheng, Yu, Zhuang, Cao, Yu, Zhao, Yuanyuan, Huang, Yan, Fang, Wenfeng, Zhang, Yang, Hong, Shaodong, Wu, Bo, Shi, Yanxia, Cao, Jingrong, Xu, Mingyan, Zhang, Xiaoni, Hu, Longyu, Peng, Bo, Yang, Yunpeng, Zhang, Li, Zhao, Hongyun |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology November 2024 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|